VSK Pharma Private Limited
About VSK Pharma Private Limited
Data last updated:
VSK Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC173981. Its GSTIN is 07AACCV7382F1Z4 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.75 Lakh. It is led by directors Shubham Bansal and Kirti Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bq – 185 Ground Floor, New Delhi, Delhi, India – 110088.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.92 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.7 Lakh (net margin 21.5%) and EBITDA of ₹2.27 Lakh (EBITDA margin 28.7%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
VSK Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBq – 185 Ground Floor, New Delhi, Delhi, India – 110088
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of VSK Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of VSK Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of VSK Pharma Private Limited, buy the company report.
Financials of VSK Pharma Private Limited
FY 2025 filings availableVSK Pharma Private Limited reported revenue of ₹7.92 Lakh (up 152% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 152% growth in the latest year. EBITDA rose 358% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.7% | ||||
| Net Profit Margin | 21.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VSK Pharma Private Limited, buy the company report.
Board of directors of VSK Pharma Private Limited
VSK Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubham Bansal Also directs: Inventive Medicare (India) LLP, Fibrient Healthcare LLP, Ethico Pharma Private Limited and 2 more | Director | 02 Aug 2019 | 7 Years 2 Months | Current |
| Kirti Gupta | Director | 26 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
VSK Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Whales Health Care Pharma Private Limited | ₹7.98 Lakh (FY 2024) | -29.0% | Patna, Bihar, India | |||
| Wulo Nutricare Private Limited | ₹7.93 Lakh (FY 2019) | 50.0% | Gurgaon, Haryana, India | |||
| VSK Pharma Private Limitedthis company | ₹7.92 Lakh (FY 2024) | ₹1.7 Lakh | 21.5% | 152.0% | New Delhi, Delhi, India | |
| Devesco Pharmaceuticals Private Limited | ₹7.92 Lakh (FY 2019) | 49.0% | New Delhi, Delhi, India | |||
| Civet Pharmaceuticals Private Limited | ₹7.89 Lakh (FY 2023) | -27.0% | Patna, Bihar, India |
To see the full peer comparison of VSK Pharma Private Limited, buy the company report.
Auditor
VSK Pharma Private Limited is audited by J D A & COMPANY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J D A & COMPANY | FY 2019 | 015377N |
Shareholding
The shareholding of VSK Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of VSK Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving VSK Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VSK Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
VSK Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCV7382F1Z4 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of VSK Pharma Private Limited, buy the company report.
Recent activity
VSK Pharma Private Limited has 10 board changes on record since 2014: 2 appointments and 8 cessations. The latest: Kirti Gupta ceased to be Additional Director on 29 Sep 2022.
1 earlier event is in the company report.
Frequently asked questions
VSK Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 February 2008 (18+ years old) and is registered under CIN U24232DL2008PTC173981.
VSK Pharma has 2 current directors:
- Shubham Bansal - Director
- Kirti Gupta - Director
The latest financial statements of VSK Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of VSK Pharma is 07AACCV7382F1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of VSK Pharma is U24232DL2008PTC173981. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VSK Pharma was incorporated on 13 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of VSK Pharma by revenue are Whales Health Care Pharma Private Limited, Wulo Nutricare Private Limited, Devesco Pharmaceuticals Private Limited, Civet Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kirti Gupta ceased to be Additional Director on 29 Sep 2022. Aayush Srisrimal ceased to be Director on 26 Apr 2022. Ajay Mittal ceased to be Director on 26 Apr 2022. VSK Pharma has 10 board changes on record in total.
The registered office of VSK Pharma is at Bq – 185 Ground Floor, New Delhi, Delhi, India – 110088.
VSK Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of VSK Pharma is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.